NCT04683419

Brief Summary

Background: Rigid thoracoscopy is the gold standard tool for diagnosing exudative pleural effusion but sometimes it is difficult to obtain sufficient biopsies using the conventional forceps. Objectives: This study evaluated the efficacy, safety and diagnostic value of a modified technique using cryoprobe to obtain pleural biopsies during thoracoscopy. Methods: This is a single center prospective study in patients who will undergo rigid thoracoscopy using conventional rigid forceps followed by a cryoprobe from the same site after injection of subpleural mixture of adrenaline and xylocaine. Biopsies will be reviewed by an independent pathologist; any complications will be recorded, and all patients will be followed up post procedure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2020

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

December 5, 2020

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 24, 2020

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2021

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2021

Completed
Last Updated

December 24, 2020

Status Verified

December 1, 2020

Enrollment Period

2 months

First QC Date

December 5, 2020

Last Update Submit

December 19, 2020

Conditions

Keywords

ThoracoscopyCryobiopsy

Outcome Measures

Primary Outcomes (3)

  • Comparison between pleural biopsy specimens obtained by modified cryoprobe technique and conventional rigid forceps during medical thoracoscopy in diagnosis of pleural effusion regarding size of the obtained pleural biopsies.

    Size of the pleural biopsies obtained by both procedures will be compared in millimeters

    Immediately after ending the procedure

  • Comparison between pleural biopsy specimens obtained by modified cryoprobe technique and conventional rigid forceps during medical thoracoscopy in diagnosis of pleural effusion regarding depth of the obtained pleural biopsies.

    Depth of the pleural biopsies obtained by both procedures will be compared by "grading of fat cells" Grading will be as follows: if there will be no presence of fat cells, this will be marked as negative and if less than 5% of the biopsy will be marked as + and if 5-25% of the biopsy will be marked as ++ and if more than 25% it will take +++ in both limbs of the cryo and forceps techniques.

    1 week

  • Comparison between pleural biopsy specimens obtained by modified cryoprobe technique and conventional rigid forceps during medical thoracoscopy in diagnosis of pleural effusion regarding integrity of the obtained pleural biopsies.

    Integrity of the pleural biopsies obtained by both procedures will be compared by percentage of "crushed cells."" Grading will be as follows: if there will be no presence of crushed cells, this will be marked as negative and if less than 5% of the biopsy will be marked as + and if 5-25% of the biopsy will be marked as ++ and if more than 25% it will take +++ in both limbs of the cryo and forceps techniques.

    1 week

Secondary Outcomes (1)

  • Safety of the procedure of thoracoscopic pleural biopsies

    During the period of hospital stay

Study Arms (1)

Patients with pleural effusion of Undetermined etiology

EXPERIMENTAL

Patients with undiagnosed exudative pleural effusion will undergo modified pleural cryobiopsies and conventional pleural forceps biopsies in the same settings

Device: Modified Thoracoscopic pleural Cryobiopsy

Interventions

Thoracoscopic pleural biopsy will be taken with a modified technique "raising of the parietal pleura by injection of saline, adrenaline and xylocaine, then taking the biopsy via a cryoprobe"

Patients with pleural effusion of Undetermined etiology

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient with undiagnosed exudative pleural effusion

You may not qualify if:

  • Any contraindications to medical thoracoscopy like:
  • Inability to tolerate lateral decubitus position Unstable cardiovascular or hemodynamic status Presence of severe, uncorrectable hypoxemia despite oxygen therapy Bleeding diathesis Refractory cough Drug Hypersensitivity Reduced general health status with short suspected survival
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chest Department, Alexandria Faculty of Medicine

Alexandria, Egypt

RECRUITING

MeSH Terms

Conditions

Pleural Effusion

Condition Hierarchy (Ancestors)

Pleural DiseasesRespiratory Tract Diseases

Study Officials

  • Ayman I Baess, PhD

    Associate Professor of Chest diseases, Alexandria University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ayman I Baess, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 5, 2020

First Posted

December 24, 2020

Study Start

November 11, 2020

Primary Completion

January 10, 2021

Study Completion

January 15, 2021

Last Updated

December 24, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Data should be confirmed in larger, multi-sites studies.

Locations